Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted Other Working Capital Changes of -$1.2 million for Q4 2025, down 3.19% on a QoQ basis from -$1.2 million in Q3 2025, and down 15.07% year-over-year from -$1.4 million in Q4 2024.
Analysis
Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings has reported Other Working Capital Changes for 5 years, with the latest figure at -$1.2 million in Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 15.07% year-over-year to -$1.2 million in Q4 2025; TTM through Dec 2025 was -$4.6 million, a 15.28% decrease from a year earlier, with the FY2025 full-year figure at -$4.6 million, down 15.28% from the prior year.
- Other Working Capital Changes was -$1.2 million for Q4 2025 at Senti Biosciences Holdings, down from -$1.2 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $700000.0 in Q4 2022, with the low at -$734000.0 in Q3 2022.
- Average Other Working Capital Changes over 3 years is -$295888.9, with a median of -$400000.0 recorded in 2021.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 4765.57% in 2022, then sank 742.48% in 2024.
- Over 5 years, Other Working Capital Changes stood at $61000.0 in 2021, then soared by 4765.57% to $3.0 million in 2022, then tumbled by 87.53% to $370000.0 in 2023, then plunged by 388.65% to -$1.1 million in 2024, then dropped by 15.07% to -$1.2 million in 2025.
- The last three Other Working Capital Changes figures came in at -$1.2 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.25 Bn | 9.40 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - |
| 3 | Iovance Biotherapeutics | 3.74 Bn | 3.45 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.58 Bn | 2.62 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.21 Bn | 1.42 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | Senti Biosciences Holdings | 9.61 Mn | 9.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -1.13 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.09 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Sep 30, 2024 | -1.03 Mn |
| Jun 30, 2024 | -983,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Mar 31, 2024 | -946,000.00 |
| Mar 31, 2024 | -946,000.00 |
| Dec 31, 2023 | 370,000.00 |
| Dec 31, 2023 | 370,000.00 |
| Sep 30, 2023 | -921,000.00 |
| Sep 30, 2023 | -921,000.00 |